Granexin is under clinical development by Xequel Bio and currently in Phase III for Radiodermatitis. According to GlobalData, Phase III drugs for Radiodermatitis does not have sufficient historical ...
Presented at the recent Conference on Robot Learning in Munich, the research comes almost four decades after the PUMA 560 became the first robot to assist in the operating room, helping with a brain ...